Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 10, 2000 - Issue 6
Submit an article Journal homepage
19
Views
7
CrossRef citations to date
0
Altmetric
Review

Cancer chemotherapeutics - angiogenesis agents: October 1999 - March 2000

Richard D Connell Cancer Drug Discovery, Pfizer Corp., MS 8118W-B2, Eastern Point Rd, Groton, CT 06340, USA. [email protected]
Pages 767-786 | Published online: 25 Feb 2005

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Richard D Connell. (2002) Patent focus on cancer chemotherapeutics V. Angiogenesis agents: September 2001 – August 2002. Expert Opinion on Therapeutic Patents 12:12, pages 1763-1782.
Read now
Richard D Connell & Jean S Beebe. (2001) Patent focus on cancer chemotherapeutics. IV Angiogenesis agents: April 2001 - August 2001. Expert Opinion on Therapeutic Patents 11:12, pages 1919-1945.
Read now
Richard D Connell & Jean S Beebe. (2001) Patent focus on cancer chemotherapeutics. III Angiogenesis agents: October 2000 – March 2001. Expert Opinion on Therapeutic Patents 11:7, pages 1171-1203.
Read now
Richard D Connell & Jean S Beebe. (2001) Patent focus on cancer chemotherapeutics. II Angiogenesis agents: April 2000 - September 2000. Expert Opinion on Therapeutic Patents 11:1, pages 77-114.
Read now
John C Kath. (2000) Patent focus: inhibitors of tumour cell growth. Expert Opinion on Therapeutic Patents 10:6, pages 803-818.
Read now

Articles from other publishers (2)

Kristi Leonard, Wenxi Pan, Beth Anaclerio, Joan M. Gushue, Zihong Guo, Renee L. DesJarlais, Marge A. Chaikin, Jennifer Lattanze, Carl Crysler, Carl L. Manthey, Bruce E. Tomczuk & Juan Jose Marugan. (2005) Non-peptidic αvβ3 antagonists containing indol-1-yl propionic acids. Bioorganic & Medicinal Chemistry Letters 15:10, pages 2679-2684.
Crossref
Michael J Morin. (2000) From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents. Oncogene 19:56, pages 6574-6583.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.